BioCryst Pharmaceuticals
BCRX
#4474
Rank
โ‚น209.64 B
Marketcap
โ‚น835.88
Share price
-3.84%
Change (1 day)
43.09%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of December 2025 : -โ‚น11.05 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has -โ‚น11.05 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$-โ‚น10.7 Billion-73.8%
2024-12-31$-โ‚น40.83 Billion7.66%
2023-12-31$-โ‚น37.93 Billion55.56%
2022-12-31$-โ‚น24.38 Billion206.14%
2021-12-31$-โ‚น7.97 Billion465.28%
2020-12-31$-โ‚น1.41 Billion-151.64%
2019-12-31$โ‚น2.72 B-20.76%
2018-12-31$โ‚น3.44 B-35.63%
2017-12-31$โ‚น5.34 B4887.84%
2016-12-31$โ‚น0.10 B-96.62%
2015-12-31$โ‚น3.17 B-33.84%
2014-12-31$โ‚น4.79 B-6990.89%
2013-12-31$-โ‚น69.57 Million179.85%
2012-12-31$-โ‚น24.86 Million-103.17%
2011-12-31$โ‚น0.78 B-73.32%
2010-12-31$โ‚น2.93 B-26.67%
2009-12-31$โ‚น4.00 B79.38%
2008-12-31$โ‚น2.23 B-12.39%
2007-12-31$โ‚น2.54 B171.86%
2006-12-31$โ‚น0.93 B-64.37%
2005-12-31$โ‚น2.62 B107.01%
2004-12-31$โ‚น1.27 B-1.91%
2003-12-31$โ‚น1.29 B-32.69%
2002-12-31$โ‚น1.92 B-29.8%
2001-12-31$โ‚น2.74 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Gilead Sciences
GILD
โ‚น2.096 T-19,082.32%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น1.991 T-18,134.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น105.70 B-1,057.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น195.17 B-1,867.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น11.84 Billion 7.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น48.85 B-542.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
โ‚น0.66 B-106.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
โ‚น1.47 B-113.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น53.98 B-588.87%๐Ÿ‡บ๐Ÿ‡ธ USA